SHO PARK: Open Payments
NPI 1225577661 · KAPOLEI, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,793 in 91 payments from 13 companies in 2025. Trend: 2023 $660 · 2024 $1,842 · 2025 $1,793
Food & beverage: $1,793
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $310 |
| Amgen Inc. | 14 | $263 |
| ABBVIE INC. | 8 | $232 |
| Novo Nordisk Inc | 17 | $220 |
| GlaxoSmithKline, LLC. | 15 | $164 |
| Lilly USA, LLC | 5 | $123 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $118 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $110 |
| Vanda Pharmaceuticals Inc. | 3 | $89 |
| Dexcom, Inc. | 2 | $47 |
Products named: QULIPTA, TRELEGY ELLIPTA, OTEZLA, FARXIGA, Wegovy, Kerendia, JARDIANCE, EVENITY.
Industry payments across HI — which companies pay providers there.
